Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-01-21 @ 10:28 PM
Study NCT ID:
NCT01802320
Status:
COMPLETED
Last Update Posted:
2019-09-20
First Post:
2013-02-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colon Mucinous Adenocarcinoma | View |
| None | Colon Signet Ring Cell Adenocarcinoma | View |
| None | Rectal Mucinous Adenocarcinoma | View |
| None | Rectal Signet Ring Cell Adenocarcinoma | View |
| None | Recurrent Colon Carcinoma | View |
| None | Recurrent Rectal Carcinoma | View |
| None | Stage IIIA Colon Cancer | View |
| None | Stage IIIA Rectal Cancer | View |
| None | Stage IIIB Colon Cancer | View |
| None | Stage IIIB Rectal Cancer | View |
| None | Stage IIIC Colon Cancer | View |
| None | Stage IIIC Rectal Cancer | View |
| None | Stage IVA Colon Cancer | View |
| None | Stage IVA Rectal Cancer | View |
| None | Stage IVB Colon Cancer | View |
| None | Stage IVB Rectal Cancer | View |
Keywords: